The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009–2021

The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009–2021

Abstract Background Cardiometabolic disease is a clinical syndrome characterized by multiple metabolic disorders, with atherosclerosis as the core and cardiovascular and cerebrovascular events as the outcome. Drug research and development (R&D) in cardiometabolic diseases has grown rapidly world...

Full description

Bibliographic Details
Main Authors: Chen Li, Jun Hao, Yitian Zheng, Chuangshi Wang, Jie Yang, Wenyao Wang, Kuo Zhang, Chunli Shao, Wen Hui, Jiancheng Wang, Wei Li, Yi-Da Tang
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Cardiometabolic disease
China
Drug clinical trial
Changing landscape
Online Access:https://doi.org/10.1186/s13098-023-01043-8

Internet

https://doi.org/10.1186/s13098-023-01043-8

Similar Items